Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells. - Wikidata - awgldk - TriplyDB

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

http://www.wikidata.org/entity/Q35075563

about

An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link Priming of protective T cell responses against virus-induced tumors in mice with human immune system components Epstein-Barr virus and Burkitt lymphoma Role of EBNA-3 Family Proteins in EBV Associated B-cell Lymphomagenesis Lymphomatoid granulomatosis and other Epstein-Barr virus associated lymphoproliferative processes EBV, HHV8 and HIV in B cell non Hodgkin lymphoma in Kampala, Uganda.Zinc coordination is required for and regulates transcription activation by Epstein-Barr nuclear antigen 1 Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infection EBV-positive Hodgkin lymphoma is associated with suppression of p21cip1/waf1 and a worse prognosis.Epstein-Barr virus nuclear antigen 3A promotes cellular proliferation by repression of the cyclin-dependent kinase inhibitor p21WAF1/CIP1.IG/MYC rearrangements are the main cytogenetic alteration in plasmablastic lymphomas.Quantitative studies of Epstein-Barr virus-encoded microRNAs provide novel insights into their regulation.EBV-associated lymphomas in adults Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Unexpected patterns of Epstein-Barr virus transcription revealed by a high throughput PCR array for absolute quantification of viral mRNA.Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells.Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders Distinct Viral and Mutational Spectrum of Endemic Burkitt Lymphoma.A Viral microRNA Cluster Regulates the Expression of PTEN, p27 and of a bcl-2 Homolog Epstein-barr virus: environmental trigger of multiple sclerosis?An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model.Memory B-cell reconstitution following allogeneic hematopoietic stem cell transplantation is an EBV-associated transformation event Immune escape by Epstein-Barr virus associated malignancies.Is the Epstein-Barr virus EBNA-1 protein an oncogen?Downregulation of the polyamine regulator spermidine/spermine N(1)-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line.Proof for EBV's sustaining role in Burkitt's lymphomas.Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus.Epidemiology: clues to the pathogenesis of Burkitt lymphoma.The Epstein-Barr virus and the pathogenesis of lymphoma.Virus-encoded microRNA contributes to the molecular profile of EBV-positive Burkitt lymphomas Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.Epigenetic Alterations in Epstein-Barr Virus-Associated Diseases.Restricted TET2 Expression in Germinal Center Type B Cells Promotes Stringent Epstein-Barr Virus Latency.Current Trends and Alternative Scenarios in EBV Research.Epstein-Barr virus in the pathogenesis of oral cancers.Different patterns of Epstein-Barr virus latency in endemic Burkitt lymphoma (BL) lead to distinct variants within the BL-associated gene expression signature.Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.Activation of p53 by MDM2 antagonists has differential apoptotic effects on Epstein-Barr virus (EBV)-positive and EBV-negative Burkitt's lymphoma cells.Multiple pathways for Epstein-Barr virus episome loss from nasopharyngeal carcinoma.

P2860

Q21131584-F2F24AFB-EAAD-4979-A0DF-357A3BCD773A Q24645297-FF87B9BA-C20C-42F6-86AC-B59F52903124 Q24669890-4B161FC1-AD8A-42F7-A034-62CA3FC4D68D Q26752541-CEBDF164-CDB0-45D8-BC44-FE0F04F0A351 Q28271456-FE6C3C31-806E-4C13-BCF7-1F77D4143FAE Q30390920-848C8E7A-BE0A-4EDB-B858-A6BDE0FECC40 Q33466782-424C4C33-0538-4424-B6FF-47D3359A4885 Q33658144-331287CD-552B-428D-8952-BF3241121696 Q33711558-403ED3D2-4786-49F8-914C-A1B35F10F330 Q34283174-12969103-843B-48D7-8BA2-BF19DA67C138 Q34314178-AFB75F5E-F5F5-4611-9359-B1E8115084A9 Q34485302-021E9161-DD5D-4E21-B6BF-BA629A58D56A Q34636601-0DC71A0A-EC48-438D-A539-E2030DC07D4D Q34658852-BA7E1918-1731-4FD5-9FF0-1D21B4DEA5BE Q34703035-73BBC155-2F99-4F46-900B-42E7DED65208 Q35181445-19EF246C-244C-47AE-9CD5-EBFEB2393AC1 Q35738744-BB7F97FA-CE29-4B40-8A4C-A9A592E2ECBB Q35808018-DBF99E98-E959-4D93-A3B5-3E40D42E0CE0 Q35901611-872F52CD-A19B-4003-92C6-A20EC4A85263 Q35914342-0769F5D2-1087-4C71-9230-2CC97CBFCE07 Q36171933-A9AF9C3E-9D98-4FE1-AC00-B3155BF48D96 Q36519976-1E858E87-4A78-4AC2-85B8-6B540C25B3A4 Q37041507-06481CE2-2760-4ADC-937F-624467B37FED Q37114721-E5A5DC62-26E2-4A46-ABB4-F28CF5ABFDCE Q37367336-9DCAE3C7-560C-475F-9966-8C61AFF960E8 Q37463625-DCC3A61B-2BC5-4C2B-BDD3-8F3BD575F389 Q37468665-68CAC403-EAA4-4B46-BFF4-693765B31435 Q37977130-B3A34314-A56A-4F2B-A465-C7AB896D7012 Q38258049-B26F02F8-7023-48FE-BABA-ED066A00C26E Q38296711-6DEF371C-7969-4C09-AB47-180E65C2F839 Q38337443-FC0D0C5A-63A1-4B4F-8E6E-AF9AB59F08D9 Q38667123-C659F5AC-CA2A-4917-859F-003E0336839A Q38724883-FF52BE61-8A15-4BE7-BE44-C1920E1FDECE Q39016336-3AFAFB1C-48AA-4D59-B41C-8A46A6A81D20 Q39132142-0068275E-7A42-41AF-9C65-D35CE82FE919 Q39220424-AB988B79-6FB0-46DE-815E-0C6506EFD66C Q39290705-BA4C20F3-1482-4EA8-A9FA-0ADD9879D36E Q39757202-E36EF879-520A-4881-BC6E-520B29EC3CFD Q39855621-E9A22021-54BE-4CE0-AF08-492CDB4AF919 Q39952661-8795222F-F2A2-4813-BAAD-CFF8FE0F349A

P2860

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

http://www.wikidata.org/entity/Q35075563

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Three restricted forms of Epst ...... essing Burkitt lymphoma cells.

@ast

Three restricted forms of Epst ...... essing Burkitt lymphoma cells.

@en

type

label

Three restricted forms of Epst ...... essing Burkitt lymphoma cells.

@ast

Three restricted forms of Epst ...... essing Burkitt lymphoma cells.

@en

prefLabel

Three restricted forms of Epst ...... essing Burkitt lymphoma cells.

@ast

Three restricted forms of Epst ...... essing Burkitt lymphoma cells.

@en

P1433

Q35075563-59A4D9C4-6B98-4384-8D1E-D58F2422C486

P1476

Q35075563-63AFCE27-336D-49A5-87EA-D1EA36BDC377

P2093

Q35075563-2A35B5A4-31EF-4BCF-88E5-D5DD950F3CA4

Q35075563-5FC0EC4F-EB4E-43AA-A968-FAF7B58B3C39

Q35075563-B4199DC8-43E1-49AD-9252-3BA067D0C014

Q35075563-F8AA9A74-28F2-4240-B41A-204A69AAA49B

P2860

Q35075563-16469474-D82D-4D83-A6C8-26444737435C

Q35075563-1FC01881-F96D-4BD6-BBF8-12E9B2BD9560

Q35075563-296CCECC-3B77-49F1-8F5B-ABF5D649A8BB

Q35075563-34B96951-78A3-4D8F-A3FC-FD212E97D173

Q35075563-38309A2B-9EEE-4875-A48B-CD91F24595A4

Q35075563-3D7BBC6C-989C-4692-B96A-A59309CA0591

Q35075563-46236DF7-7CBB-4482-A1ED-38FDB9231225

Q35075563-487DEAD6-A4EF-4902-BBAB-7BB1ED2B8C79

Q35075563-48E927BA-4FCA-4E67-96E1-AED4255609C1

Q35075563-688CFBDD-CAD0-45C5-B88B-F54784E1C743

P304

Q35075563-19D32D08-971C-4954-A0BF-B78A646B6012

P31

Q35075563-D9226817-85BB-4B5F-8EF6-B7FA5E1E3760

P356

Q35075563-25289AB0-1355-4716-B962-CF7FF61EF7FE

P407

Q35075563-3DD967BC-0E28-4011-B046-E91E2B90532E

P433

Q35075563-D275DF44-5A35-488D-934A-B10204C601A3

P478

Q35075563-8416C28E-47BC-4C5B-ACA3-EE6235A0B5E9

P50

Q35075563-17F3F54B-43B4-4298-AE77-BE519721704F

P577

Q35075563-CFC4902E-B2D6-407D-927D-42A137B10798

P5875

Q35075563-B36D1FAE-0C14-4362-9DCF-B16E1616BDBA

P698

Q35075563-11A0D066-7E56-4119-949F-0C57EEF1F79D

P921

Q35075563-01EB773D-3F4D-4F93-8C5A-9E709CFB9A57

Q35075563-093F3FB5-1190-4F0E-A12E-7845C6F26DE1

P932

Q35075563-D624BE68-FC06-4A9E-8731-3C6B455F1362

P356

PNAS.0509988103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Three restricted forms of Epst ...... ressing Burkitt lymphoma cells

@en

P2093

Alan B Rickinson

http://www.w3.org/2001/XMLSchema#string

Anne E Milner

http://www.w3.org/2001/XMLSchema#string

Gemma L Kelly

http://www.w3.org/2001/XMLSchema#string

Gouri S Baldwin

http://www.w3.org/2001/XMLSchema#string

P2860

Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt's lymphoma cell line Akata

c-MYC: more than just a matter of life and death

Absence of Epstein-Barr virus DNA in the tumor cells of European hepatocellular carcinoma.

Epstein-Barr virus provides a survival factor to Burkitt's lymphomas.

Epstein-Barr virus nuclear antigen 2 (EBNA2) gene deletion is consistently linked with EBNA3A, -3B, and -3C expression in Burkitt's lymphoma cells and with increased resistance to apoptosis.

Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells

Latent Marek's disease virus can be activated from its chromosomally integrated state in herpesvirus-transformed lymphoma cells.

Epstein-Barr virus EBNA2 blocks Nur77- mediated apoptosis

Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction.

B cells under influence: transformation of B cells by Epstein-Barr virus.

P304

14935-14940

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0509988103

http://www.w3.org/2001/XMLSchema#string

P407

P433

40

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6793707

http://www.w3.org/2001/XMLSchema#string

P698

17001014

http://www.w3.org/2001/XMLSchema#string

P921

Burkitt lymphoma

Epstein–Barr virus

P932

1595454

http://www.w3.org/2001/XMLSchema#string